1. Home
  2. TG vs BDTX Comparison

TG vs BDTX Comparison

Compare TG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.56

Market Cap

301.0M

Sector

Industrials

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$2.79

Market Cap

220.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
BDTX
Founded
1988
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
301.0M
220.3M
IPO Year
1989
2020

Fundamental Metrics

Financial Performance
Metric
TG
BDTX
Price
$7.56
$2.79
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$10.60
AVG Volume (30 Days)
174.6K
1.7M
Earning Date
11-07-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.38
Revenue
$691,173,000.00
$70,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$117.16
$7.30
Revenue Growth
43.30
N/A
52 Week Low
$6.25
$1.20
52 Week High
$9.43
$4.94

Technical Indicators

Market Signals
Indicator
TG
BDTX
Relative Strength Index (RSI) 46.39 33.21
Support Level $7.48 $2.61
Resistance Level $7.90 $2.87
Average True Range (ATR) 0.24 0.26
MACD -0.05 -0.08
Stochastic Oscillator 14.49 32.94

Price Performance

Historical Comparison
TG
BDTX

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: